Integrated BioTherapeutics
20358 Seneca Meadows Parkway
Germantown
Maryland
20876
United States
Tel: 240-454-8934
Fax: 301-515-0324
Website: http://www.integratedbiotherapeutics.com/
Email: info@ibtinc-usa.com
8 articles about Integrated BioTherapeutics
-
Integral Molecular and Integrated BioTherapeutics Collaborate to Engineer Broadly Protective Ebolavirus Vaccines
11/2/2021
A collaboration between Integral Molecular and Integrated BioTherapeutics, two biotechnology companies with deep expertise in virology, has resulted in engineered proteins that may enable next-generation vaccines with broad protection against Ebola and related viruses.
-
Integrated Biotherapeutics Partners With CARB-X the First Toxoid Based Multivalent Vaccine for Methicillin-Resistant Staphylococcus Aureus
11/2/2017
Integrated BioTherapeutics announced today that is has been awarded up to $168,000, with the possibility of up to $8.3M more based on the achievement of milestones, to develop the first entirely toxoid-based multivalent vaccine for the prevention of MRSA.
-
Integrated BioTherapeutics, In Collaboration With The Scripps Research Institute, Receives NIH Funding To Develop A Rationally Designed Pan-Ebolavirus Vaccine
8/2/2017
-
Integrated BioTherapeutics Release: Immunization Elicited Antibody Shows Universal Protection Against Multiple Ebolaviruses
5/18/2017
-
Integral Molecular, Inc. And Integrated BioTherapeutics Initiate Collaboration For Virus Vaccine Discovery
3/3/2017
-
Integrated BioTherapeutics Announces Licensing Agreement With Emergent BioSolutions For Development Of Equine Immunoglobulin Therapeutics For Filovirus Infections
11/15/2016
-
Chembio Diagnostics, Inc. Partners With Integrated BioTherapeutics To Develop Point-Of-Care Diagnostic Tests For Ebola And Febrile Illness
10/27/2014
-
Integrated BioTherapeutics Release: New Bioterrorism Vaccine Gets First Test In Humans
2/27/2013